TORONTO - FUJIFILM VisualSonics Inc., a world leader in ultra high frequency ultrasound and photoacoustic imaging systems and subsidiary of FUJIFILM SonoSite, Inc., has launched the Vevo F2, the world’s first ultra high to low frequency ultrasound imaging system with a frequency range stretching from 71-1 MHz.
For over twenty years, FUJIFILM VisualSonics has been delivering the best-in-class, ultra high frequency ultrasound and photoacoustic imaging solutions to the scientific research community. With the Vevo F2, FUJIFILM VisualSonics is expanding their reach to satisfy the imaging needs of acoustic researchers, ultrasound engineers and all those that would benefit from ultra high to low frequency imaging capabilities, and an open and configurable architecture that also supports photoacoustics.
Equipped with Vevo Advanced Data Acquisition (VADA), the Vevo F2 allows access to pre-beamformed individual channel data via an all new, easy-to-use, graphical user interface. With full control over transmit profiles, researchers now have the power and freedom to develop and explore new imaging methods in a quick, iterative fashion—going beyond existing imaging modes.
“The Vevo F2 fills a gap in the tools available to biomedical engineering and acoustic researchers. By providing an integrated and optimized high to low frequency system that leverages an easy to use interface for configuration, our customers can expand both their capabilities and efficiency. Vevo F2 users will also benefit from a worldwide service and support infrastructure,” stated Greg Nesbitt, vice president, global high frequency.
Possible target areas of research using the Vevo F2 include the implementation of plane-wave techniques for ultrafast ultrasound imaging for applications such as ultrafast Doppler, super-resolution ultrasound, and beamforming algorithm development. The Vevo F2 also allows for synchronization with external devices to coordinate timing between HIFU pulses for imaging, or shear wave generation for elastography measurements.
“The Vevo F2 imaging system is the result of many years of hard work from our product development teams. Combining the best of both high and low frequency ultrasound into a single platform was not without technical challenges, however, our team was able to create a truly remarkable system. Not only does it provide such a large bandwidth, it has the flexibility and access to data required by the ultrasound research community, while still being extremely user-friendly. We look forward to seeing this new technology in the hands of our customers who we know will do amazing things with it,” shared Andrew Needles, director, marketing and product management.
The Vevo F2 is already being utilized at select beta sites including Lund University in Sweden. Magnus Cinthio, Associate Professor, shared the following about his experience with the Vevo F2:“The possibility of working with low and high frequency is really interesting. The VADA interface is intuitive and very easy to work with. The combination of VADA and the broadband frequencies are clear differentiators of Vevo F2 over other providers.” On May 27, 2020, FUJIFILM VisualSonics hosted their first-ever virtual product launch to introduce the Vevo F2.
FUJIFILM VisualSonics, Inc., is a global leader in real time, in vivo, ultra high frequency ultrasound and photoacoustic imaging systems. With headquarters in Toronto, Canada and offices around the world, FUJIFILM VisualSonics is represented globally across an integrated sales network. FUJIFILM VisualSonics is recognized worldwide for providing cutting edge imaging technologies for the advancement of preclinical research, particularly in cardiovascular, oncology, neurobiology and developmental biology areas. With the expansion of the product portfolio to include a new clinical product, FUJIFILM VisualSonics now broadens their range of imaging technologies across both preclinical and clinical markets. FUJIFILM VisualSonics is a subsidiary of FUJIFILM SonoSite, Inc. and a part of FUJIFILM Holdings Corporation. For more information, please go to: www.visualsonics.com.
FUJIFILM SonoSite, Inc. is the innovator and world leader in bedside and point-of-care ultrasound, and an industry leader in ultra high-frequency micro-ultrasound technology. Headquartered near Seattle, the company is represented by 26 subsidiaries and a global distribution network in over 100 countries. SonoSite’s portable, compact systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. For more information, go to: www.sonosite.com.
FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.